New NIH/FDA Rules Will Bring Greater Transparency to Clinical Trials: The big stick is withholding grant funds

    loading  Checking for direct PDF access through Ovid

Abstract

The new rules published this fall by the NIH and FDA about reporting clinical trial results will expand transparency in research and give the world more knowledge about the effectiveness of investigational and new drugs and devices, FDA and NIH officials say.

Related Topics

    loading  Loading Related Articles